Franco Mantero Selected Research

Franco Mantero Research Topics

Disease

38	Adenoma (Adenomas) 01/2018 - 05/2003
30	Hyperaldosteronism (Conn Syndrome) 01/2018 - 03/2002
25	Neoplasms (Cancer) 10/2018 - 01/2002
21	Hypertension (High Blood Pressure) 12/2019 - 08/2003
20	Cushing Syndrome 01/2018 - 11/2002
7	Hyperplasia 01/2016 - 09/2008
6	Adrenal incidentaloma 01/2018 - 11/2002
6	Adrenocortical Carcinoma 10/2016 - 09/2005
6	Adrenal Insufficiency (Adrenal Gland Hypofunction) 12/2013 - 06/2002
5	Pituitary ACTH Hypersecretion 07/2014 - 12/2004
5	Pituitary Neoplasms (Pituitary Adenoma) 01/2014 - 09/2003
5	Pheochromocytoma 08/2007 - 01/2005
4	Insulin Resistance 01/2014 - 02/2006
4	Obesity 09/2006 - 01/2002
3	Essential Hypertension 01/2018 - 08/2005
3	Carcinogenesis 10/2016 - 01/2002
3	Hypokalemia 01/2016 - 09/2008
3	Carcinoma (Carcinomatosis) 09/2013 - 12/2004
3	Papillary Thyroid Cancer 12/2011 - 01/2008
2	Necrosis 01/2014 - 09/2013
2	Autoimmune Diseases (Autoimmune Disease) 12/2013 - 06/2002
2	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2013 - 06/2002
2	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 01/2013 - 08/2012
2	Overweight 07/2008 - 05/2002
2	Addison Disease (Addison's Disease) 05/2006 - 04/2004
2	ACTH-Secreting Pituitary Adenoma 02/2006 - 01/2004
2	Asthenozoospermia 09/2005 - 01/2004
2	Acromegaly 01/2005 - 09/2003
2	Body Weight (Weight, Body) 05/2004 - 01/2002
2	Alkalosis 08/2003 - 03/2002
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2018
1	Liddle Syndrome 01/2018
1	Atrial Fibrillation 01/2018
1	Lung Neoplasms (Lung Cancer) 10/2016
1	Neoplasm Metastasis (Metastasis) 10/2016
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 07/2014
1	Polycythemia (Erythrocytosis) 01/2014

Drug/Important Bio-Agent (IBA)

34	AldosteroneIBA 12/2019 - 05/2003
22	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2019 - 01/2002
11	ReninIBA 12/2019 - 04/2005
9	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2015 - 01/2002
8	GlucocorticoidsIBA 01/2013 - 11/2002
7	Hormones (Hormone)IBA 01/2016 - 05/2003
5	AutoantibodiesIBA 01/2015 - 06/2002
5	MineralocorticoidsIBA 02/2014 - 08/2003
5	SteroidsIBA 12/2011 - 01/2002
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2002
4	Mineralocorticoid Receptor AntagonistsIBA 01/2016 - 09/2008
4	Dexamethasone (Maxidex)FDA LinkGeneric 10/2015 - 01/2002
4	Mitotane (Lysodren)FDA Link 01/2013 - 09/2005
4	Captopril (Capoten)FDA LinkGeneric 09/2010 - 04/2006
4	Messenger RNA (mRNA)IBA 01/2008 - 05/2002
3	Cortisone FDA Link 01/2018 - 02/2014
3	EnzymesIBA 01/2015 - 06/2002
3	Codon (Codons)IBA 05/2014 - 01/2002
3	Insulin-Like Growth Factor I (IGF-1)IBA 05/2011 - 09/2003
2	CateninsIBA 10/2016 - 01/2016
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2016 - 10/2014
2	Antihypertensive Agents (Antihypertensives)IBA 04/2015 - 01/2010
2	AndrogensIBA 10/2014 - 01/2013
2	Oxidoreductases (Dehydrogenase)IBA 02/2014 - 09/2006
2	Everolimus FDA Link 01/2014 - 08/2012
2	Cisplatin (Platino)FDA LinkGeneric 06/2012 - 09/2005
2	Etoposide (VP 16)FDA LinkGeneric 06/2012 - 09/2005
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2012 - 09/2005
2	Biological ProductsIBA 03/2012 - 08/2011
2	DNA (Deoxyribonucleic Acid)IBA 03/2012 - 01/2002
2	Biomarkers (Surrogate Marker)IBA 12/2011 - 10/2010
2	von Willebrand FactorIBA 01/2011 - 01/2008
2	nasIBA 07/2010 - 09/2005
2	SodiumIBA 07/2008 - 08/2007
2	IodineIBA 01/2008 - 11/2003
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2007 - 03/2006
2	11-beta-Hydroxysteroid Dehydrogenase Type 2 (11 beta-Hydroxysteroid Dehydrogenase Type 2)IBA 08/2005 - 08/2003
2	Corticotropin Receptors (ACTH Receptor)IBA 05/2003 - 01/2002
1	CatecholaminesIBA 12/2019
1	ElectrolytesIBA 12/2019
1	Nonsense Codon (Nonsense Mutation)IBA 10/2018
1	Mitochondrial DNA (mtDNA)IBA 01/2018
1	SNS 314IBA 10/2016
1	Aurora KinasesIBA 10/2016
1	VX (EDIM)IBA 10/2016
1	tozasertibIBA 10/2016
1	Serine (L-Serine)FDA Link 10/2016
1	4- (4- (N- benzoylamino)anilino)- 6- methoxy- 7- (3- (1- morpholino)propoxy)quinazolineIBA 10/2016
1	Threonine (L-Threonine)FDA Link 10/2016
1	Cadherins (E-Cadherin)IBA 10/2016
1	reversanIBA 10/2016
1	ImmunosorbentsIBA 01/2015
1	Type 1 Angiotensin ReceptorIBA 01/2015
1	Mitogen-Activated Protein KinasesIBA 01/2015
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2014
1	FITC-annexin A5IBA 01/2014
1	Propidium (Propidium Iodide)IBA 01/2014
1	Temozolomide (Temodar)FDA LinkGeneric 01/2014

Therapy/Procedure

13	Adrenalectomy 01/2018 - 10/2004
11	Therapeutics 01/2018 - 06/2002
2	Glycemic Control 01/2014 - 05/2008
2	Radiotherapy 05/2011 - 09/2004
2	Length of Stay 08/2007 - 06/2007